🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/06/2006 | 37,24 | 37,43 | 36,31 | 37,06 | -0,50% | 3,02% | 48.010 |
| 15/06/2006 | 36,57 | 38,37 | 36,57 | 37,24 | +0,51% | 4,91% | 28.240 |
| 14/06/2006 | 39,30 | 39,30 | 35,97 | 37,06 | -1,00% | 8,48% | 138.633 |
| 13/06/2006 | 40,16 | 40,80 | 37,24 | 37,43 | -6,98% | 8,85% | 125.969 |
| 12/06/2006 | 41,36 | 41,73 | 40,12 | 40,24 | -2,27% | 3,89% | 58.296 |
| 09/06/2006 | 40,80 | 41,92 | 40,80 | 41,17 | +1,38% | 2,75% | 38.659 |
| 08/06/2006 | 41,88 | 41,92 | 40,24 | 40,61 | -3,12% | 4,02% | 146.461 |
| 07/06/2006 | 41,02 | 42,11 | 40,61 | 41,92 | +1,82% | 3,65% | 29.896 |
| 06/06/2006 | 42,11 | 42,30 | 40,24 | 41,17 | -2,65% | 4,89% | 49.105 |
| 05/06/2006 | 42,63 | 42,63 | 42,00 | 42,30 | -0,44% | 1,49% | 73.097 |
| 02/06/2006 | 40,87 | 42,48 | 40,87 | 42,48 | +3,75% | 3,94% | 93.776 |
| 01/06/2006 | 40,95 | 41,14 | 40,50 | 40,95 | -0,09% | 1,55% | 119.611 |
| 31/05/2006 | 42,11 | 42,11 | 40,50 | 40,99 | -0,90% | 3,82% | 95.993 |
| 30/05/2006 | 39,49 | 41,73 | 39,49 | 41,36 | +4,74% | 5,69% | 199.440 |
| 26/05/2006 | 38,55 | 39,68 | 38,37 | 39,49 | +2,93% | 3,40% | 203.207 |
| 25/05/2006 | 37,62 | 38,37 | 37,24 | 38,37 | +1,49% | 2,99% | 106.519 |
| 24/05/2006 | 37,17 | 37,80 | 35,93 | 37,80 | +1,41% | 5,04% | 130.003 |
| 23/05/2006 | 37,95 | 39,45 | 37,28 | 37,28 | -1,87% | 5,72% | 283.784 |
| 22/05/2006 | 37,06 | 38,37 | 35,63 | 37,99 | +2,53% | 7,37% | 159.525 |
| 19/05/2006 | 36,57 | 37,80 | 36,31 | 37,06 | +1,54% | 4,09% | 267.541 |
| 18/05/2006 | 38,22 | 38,22 | 35,18 | 36,49 | -4,88% | 7,93% | 525.517 |
| 17/05/2006 | 39,49 | 39,49 | 37,80 | 38,37 | -3,76% | 4,27% | 206.173 |
| 16/05/2006 | 41,36 | 41,70 | 38,55 | 39,86 | -4,48% | 7,60% | 233.397 |
| 15/05/2006 | 43,23 | 43,23 | 41,55 | 41,73 | -4,13% | 3,90% | 51.162 |
| 12/05/2006 | 42,89 | 43,53 | 42,86 | 43,53 | +1,13% | 1,57% | 79.482 |
| 11/05/2006 | 41,36 | 43,04 | 41,36 | 43,04 | +4,07% | 4,07% | 90.596 |
| 10/05/2006 | 42,41 | 42,41 | 40,42 | 41,36 | -2,47% | 4,68% | 73.150 |
| 09/05/2006 | 43,23 | 43,23 | 42,11 | 42,41 | -1,48% | 2,60% | 40.422 |
| 08/05/2006 | 42,82 | 43,42 | 42,82 | 43,04 | +0,00% | 1,40% | 41.518 |
| 05/05/2006 | 43,23 | 43,98 | 42,86 | 43,04 | -0,26% | 2,60% | 31.392 |